The CXCR3 targeting chemokine CXCL11 has potent antitumor activity in vivo involving attraction of CD8+ T lymphocytes but not inhibition of angiogenesis.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples